Ulrike Gradhand

700 total citations
10 papers, 537 citations indexed

About

Ulrike Gradhand is a scholar working on Oncology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ulrike Gradhand has authored 10 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ulrike Gradhand's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). Ulrike Gradhand is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). Ulrike Gradhand collaborates with scholars based in Germany, Canada and United States. Ulrike Gradhand's co-authors include Martin F. Fromm, Jörg König, Annick Seithel, Richard B. Kim, Heike Tegude, Michel Eichelbaum, Thomas Lang, Péter Fritz, Ulrich M. Zanger and Matthias Schwab and has published in prestigious journals such as Life Sciences, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Ulrike Gradhand

8 papers receiving 521 citations

Peers

Countries citing papers authored by Ulrike Gradhand

Since Specialization

Citations

This map shows the geographic impact of Ulrike Gradhand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Gradhand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Gradhand more than expected).

Fields of papers citing papers by Ulrike Gradhand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Gradhand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Gradhand. The network helps show where Ulrike Gradhand may publish in the future.

Co-authorship network of co-authors of Ulrike Gradhand

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Gradhand. A scholar is included among the top collaborators of Ulrike Gradhand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Gradhand. Ulrike Gradhand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	In vitro-in vivo extrapolation of intrinsic clearance based on data from human hepatocyte spheroids – a case study with the low-clearance drug xevinapant 2025 ·Xenobiotica ·Dominik Jacob, Ulrike Gradhand, Christine K. Maurer, (unknown), (unknown), Margit Hagel, Jonny Nachtigall, (unknown), L. Richter, (unknown), Annick Ménétrey, Felix Rohdich	0
2	Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Sathej Gopalakrishnan, Özkan Yalkinoglu, (unknown), Hong Lü, Kosalaram Goteti, Axel Krebs‐Brown, (unknown), Ulrike Gradhand, Markus Fluck, (unknown), Jennifer Dong, Karthik Venkatakrishnan	13
3	Evobrutinib pathway to its major metabolite M463-2 and insights from a biotransformation and DDI perspective 2023 ·Xenobiotica ·(unknown), Hanno Schieferstein, Ralf Schmidt, Klaus Pusecker, Ulrike Gradhand, Sathej Gopalakrishnan, Khalid Iqbal, Jennifer Dong, (unknown), (unknown), Jayaprakasam Bolleddula, Martin C. Dyroff, Katrin Georgi	0
4	Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity 2013 ·Drug Metabolism and Disposition ·Christopher C. Arico-Muendel, Bruce Belanger, Dennis R. Benjamin, (unknown), (unknown), Jennifer L. DeLorey, (unknown), Ulrike Gradhand, (unknown), Susan E. Hill, Matthew Labenski, Barry A. Morgan, Gary O’Donovan, Kavirayani R. Prasad, Steven R. Skinner, (unknown), Charles D. Thompson, James Wakefield, William Westlin, Kerry White	9
5	Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2‐/‐ Mice and Intraindividual Variability in Human Subjects 2011 ·The Journal of Clinical Pharmacology ·Marianne K. DeGorter, Bradley L. Urquhart, Ulrike Gradhand, Rommel G. Tirona, Richard B. Kim	26
6	Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2) 2008 ·Drug Metabolism Reviews ·Ulrike Gradhand, Richard B. Kim	74
7	6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4 2008 ·Human Mutation ·(unknown), Sherif Mehralivand, Dennis Strand, Ute Gödtel‐Armbrust, Alice Habermeier, Ulrike Gradhand, Christine Fischer, Mohammad R. Toliat, Péter Fritz, Ulrich M. Zanger, Matthias Schwab, Martin F. Fromm, Peter Nürnberg, Leszek Wojnowski, Ellen I. Closs, Thomas Lang	43
8	Functional analysis of the polymorphism −211C>T in the regulatory region of the human ABCC3 gene 2007 ·Life Sciences ·Ulrike Gradhand, Heike Tegude, Oliver Burk, Michel Eichelbaum, Martin F. Fromm, Jörg König	20
9	Variability in human hepatic MRP4 expression: influence of cholestasis and genotype 2007 ·The Pharmacogenomics Journal ·Ulrike Gradhand, Thomas Lang, Elke Schaeffeler, Hartmut Glaeser, Heike Tegude, Kathrin Klein, Péter Fritz, Gabriele Jedlitschky, H K Kroemer, Iouri Bachmakov, (unknown), Reinhold Kerb, Ulrich M. Zanger, Michel Eichelbaum, Matthias Schwab, Martin F. Fromm	72
10	Pharmacogenomics of human OATP transporters 2006 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Jörg König, Annick Seithel, Ulrike Gradhand, Martin F. Fromm	280

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact